UpHill key facts
as of Oct 2026- Developer of a clinical pathway software designed to integrate with existing hospital information systems to automate tasks and bridge gaps in care.
- UpHill is valued at approximately $23.6M as of Oct 2026 (last reported valuation).
- It has raised $12.5M; the latest was PE Growth/Expansion in Dec 2025.
- Notable investors include Redstone VC, Explorer Investments, Oxy Capital, Caixa Capital, Brighteye Ventures — 13 tracked in total.
- Status: Privately Held (backing).
UpHill's last reported valuation, Mar 2024. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch UpHill: the Monday email on marks, rounds and moves
UpHill funding rounds
No funding rounds for UpHill are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs UpHill
13+UpHill valuation
UpHill's last reported valuation was $23.6 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.
UpHill investors
13 investors are on record for UpHill, including Redstone VC, Explorer Investments, Oxy Capital and Caixa Capital.
About UpHill
Developer of a clinical pathway software designed to integrate with existing hospital information systems to automate tasks and bridge gaps in care. The company offers software orchestrating care where hospitals have a comprehensive view of their patient's status throughout their journeys as individuals and as a population, including history and expected next steps, enabling the healthcare industry to automate medical tests and appointments, monitor patients after discharge, intelligently interpret patients' answers, present the next best actions to be done, and get records proposed to the electronic health records system.
- Sector
- Healthcare
- HQ
- Covilha, Portugal
- Founded
- 2015
- Employees
- 46
- Website
- uphillhealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.